View Item 

Show simple item record

Lorecivivint, a Novel Intraarticular CDC‐like Kinase 2 and Dual‐Specificity Tyrosine Phosphorylation‐Regulated Kinase 1A Inhibitor and Wnt Pathway Modulator for the Treatment of Knee Osteoarthritis: A Phase II Randomized Trial
dc.contributor.authorYazici, Yusuf
dc.contributor.authorMcAlindon, Timothy E.
dc.contributor.authorGibofsky, Allan
dc.contributor.authorLane, Nancy E.
dc.contributor.authorClauw, Daniel
dc.contributor.authorJones, Morgan
dc.contributor.authorBergfeld, John
dc.contributor.authorSwearingen, Christopher J.
dc.contributor.authorDiFrancesco, Anita
dc.contributor.authorSimsek, Ismail
dc.contributor.authorTambiah, Jeyanesh
dc.contributor.authorHochberg, Marc C.
dc.date.accessioned2020-10-01T23:32:24Z
dc.date.availableWITHHELD_13_MONTHS
dc.date.available2020-10-01T23:32:24Z
dc.date.issued2020-10
dc.identifier.citationYazici, Yusuf; McAlindon, Timothy E.; Gibofsky, Allan; Lane, Nancy E.; Clauw, Daniel; Jones, Morgan; Bergfeld, John; Swearingen, Christopher J.; DiFrancesco, Anita; Simsek, Ismail; Tambiah, Jeyanesh; Hochberg, Marc C. (2020). "Lorecivivint, a Novel Intraarticular CDC‐like Kinase 2 and Dual‐Specificity Tyrosine Phosphorylation‐Regulated Kinase 1A Inhibitor and Wnt Pathway Modulator for the Treatment of Knee Osteoarthritis: A Phase II Randomized Trial." Arthritis & Rheumatology 72(10): 1694-1706.
dc.identifier.issn2326-5191
dc.identifier.issn2326-5205
dc.identifier.urihttps://hdl.handle.net/2027.42/162805
dc.publisherUnited States Bone and Joint Initiative
dc.publisherWiley Periodicals, Inc.
dc.titleLorecivivint, a Novel Intraarticular CDC‐like Kinase 2 and Dual‐Specificity Tyrosine Phosphorylation‐Regulated Kinase 1A Inhibitor and Wnt Pathway Modulator for the Treatment of Knee Osteoarthritis: A Phase II Randomized Trial
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelRheumatology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/162805/2/art41315_am.pdfen_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/162805/1/art41315.pdfen_US
dc.identifier.doi10.1002/art.41315
dc.identifier.sourceArthritis & Rheumatology
dc.identifier.citedreferenceRiddle DL, Stratford PW. Unilateral vs bilateral symptomatic knee osteoarthritis: associations between pain intensity and function. Rheumatology (Oxford) 2013; 52: 2229 – 37.
dc.identifier.citedreferenceYazici Y, McAlindon TE, Fleischmann R, Gibofsky A, Lane NE, Kivitz AJ, et al. A novel Wnt pathway inhibitor, LOR, for the treatment of moderate to severe osteoarthritis of the knee: results of a 24‐week, randomized, controlled, phase 1 study. Osteoarthritis Cartilage 2017; 25: 1598 – 606.
dc.identifier.citedreferenceDeshmukh V, O’Green AL, Bossard C, Seo T, Lamangan L, Ibanez M, et al. Modulation of the Wnt pathway through inhibition of CLK2 and DYRK1A by lorecivivint as a novel, potentially disease‐modifying approach for knee osteoarthritis treatment. Osteoarthritis Cartilage 2019; 27: 1347 – 60.
dc.identifier.citedreferenceDupuis DE, Beynnon BD, Richard MJ, Novotny JE, Skelly JM, Cooper SM. Precision and accuracy of joint space width measurements of the medial compartment of the knee using standardized MTP semi‐flexed radiographs. Osteoarthritis Cartilage 2003; 11: 716 – 24.
dc.identifier.citedreferenceAltman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et al. Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee. Arthritis Rheum 1986; 29: 1039 – 49.
dc.identifier.citedreferenceKellgren JH, Lawrence JS, editors. The epidemiology of chronic rheumatism: atlas of standard radiographs. Vol. II. Oxford: Blackwell Scientific; 1962.
dc.identifier.citedreferenceHawker GA, Mian S, Kendzerska T, French M. Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short‐Form McGill Pain Questionnaire (SF‐MPQ), Chronic Pain Grade Scale (CPGS), Short Form‐36 Bodily Pain Scale (SF‐36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP). Arthritis Care Res (Hoboken) 2011; 63: S240 – 52.
dc.identifier.citedreferenceMcConnell S, Kolopack P, Davis AM. The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC): a review of its utility and measurement properties. Arthritis Rheum 2001; 45: 453 – 61.
dc.identifier.citedreferenceWolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken) 2010; 62: 600 – 10.
dc.identifier.citedreferencePiantadosi S, editor. Clinical trials: a methodologic perspective. Hoboken (NJ); Wiley‐Interscience; 1997.
dc.identifier.citedreferenceDmitrienko A, Tamhane AC, Bretz F, editors. Multiple testing problems in pharmaceutical statistics. Boca Raton (FL): CRC Press; 2010.
dc.identifier.citedreferenceHosmer DW, Lemeshow S, editors. Applied logistic regression. 2nd edition. New York: John Wiley & Sons; 2000.
dc.identifier.citedreferenceStrand V, Boers M, Idzerda L, Kirwan JR, Kvien TK, Tugwell PS, et al. It’s good to feel better but it’s better to feel good and even better to feel good as soon as possible for as long as possible: response criteria and the importance of change at OMERACT 10. J Rheumatol 2011; 38: 1720 – 7.
dc.identifier.citedreferenceNeogi T, Felson D, Niu J, Nevitt M, Lewis CE, Aliabadi P, et al. Association between radiographic features of knee osteoarthritis and pain: results from two cohort studies. BMJ 2009; 339: b2844.
dc.identifier.citedreferenceClauw DJ, Hassett AL. The role of centralised pain in osteoarthritis. Clin Exp Rheumatol 2017; 35 Suppl 107: 79 – 84.
dc.identifier.citedreferenceRaynauld JP, Martel‐Pelletier J, Haraoui B, Choquette D, Dorais M, Wildi LM, et al. Risk factors predictive of joint replacement in a 2‐year multicentre clinical trial in knee osteoarthritis using MRI: results from over 6 years of observation. Ann Rheum Dis 2011; 70: 1382 – 8.
dc.identifier.citedreferenceBruyere O, Richy F, Reginster JY. Three year joint space narrowing predicts long term incidence of knee surgery in patients with osteoarthritis: an eight year prospective follow up study. Ann Rheum Dis 2005; 64: 1727 – 30.
dc.identifier.citedreferenceBruyere O, Genant H, Kothari M, Zaim S, White D, Peterfy C, et al. Longitudinal study of magnetic resonance imaging and standard x‐rays to assess disease progression in osteoarthritis. Osteoarthritis Cartilage 2007; 15: 98 – 103.
dc.identifier.citedreferenceBenichou OD, Hunter DJ, Nelson D, Guermazi A, Eckstein F, Kwoh K, et al. One‐year change in radiographic joint space width in patients with unilateral joint space narrowing: data from the Osteoarthritis Initiative. Arthritis Care Res (Hoboken) 2010; 62: 924 – 31.
dc.identifier.citedreferenceBuckland‐Wright JC, Ward RJ, Peterfy C, Mojcik CF, Leff RL. Reproducibility of the semiflexed (metatarsophalangeal) radiographic knee position and automated measurements of medial tibiofemoral joint space width in a multicenter clinical trial of knee osteoarthritis. J Rheumatol 2004; 31: 1588 – 97.
dc.identifier.citedreferenceNevitt MC, Peterfy C, Guermazi A, Felson DT, Duryea J, Woodworth T, et al. Longitudinal performance evaluation and validation of fixed‐flexion radiography of the knee for detection of joint space loss. Arthritis Rheum 2007; 56: 1512 – 20.
dc.identifier.citedreferenceHunter DJ, Zhang W, Conaghan PG, Hirko K, Menashe L, Reichmann WM, et al. Responsiveness and reliability of MRI in knee osteoarthritis: a meta‐analysis of published evidence. Osteoarthritis Cartilage 2011; 19: 589 – 605.
dc.identifier.citedreferenceCreaby MW, Bennell KL, Hunt MA. Gait differs between unilateral and bilateral knee osteoarthritis. Arch Phys Med Rehabil 2012; 93: 822 – 7.
dc.identifier.citedreferenceWaller C, Hayes D, Block JE, London NJ. Unload it: the key to the treatment of knee osteoarthritis. Knee Surg Sports Traumatol Arthrosc 2011; 19: 1823 – 9.
dc.identifier.citedreferenceAltman RD, Devji T, Bhandari M, Fierlinger A, Niazi F, Christensen R. Clinical benefit of intraarticular saline as a comparator in clinical trials of knee osteoarthritis treatments: a systematic review and meta‐analysis of randomized trials. Semin Arthritis Rheum 2016; 46: 151 – 9.
dc.identifier.citedreferenceBannuru RR, McAlindon TE, Sullivan MC, Wong JB, Kent DM, Schmid CH. Effectiveness and implications of alternative placebo treatments: a systematic review and network meta‐analysis of osteoarthritis trials. Ann Intern Med 2015; 163: 365 – 72.
dc.identifier.citedreferenceHochberg MC, Cisternas MG. Osteoarthritis. In: The burden of musculoskeletal diseases in the United States (BMUS). 4th ed. Rosemont (IL): United States Bone and Joint Initiative; 2019.
dc.identifier.citedreferenceConaghan PG, Hunter DJ, Maillefert JF, Reichmann WM, Losina E. Summary and recommendations of the OARSI FDA Osteoarthritis Assessment of Structural Change working group. Osteoarthritis Cartilage 2011; 19: 606 – 10.
dc.identifier.citedreferenceHochberg MC, Altman RD, April KT, Benkhalti M, Guyatt G, McGowan J, et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of hand, hip, and knee. Arthritis Care Res (Hoboken) 2012; 64: 465 – 74.
dc.identifier.citedreferenceMcAlindon TE, Bannuru RR, Sullivan MC, Arden NK, Berenbaum F, Bierma‐Zeinstra SM, et al. OARSI guidelines for the non‐surgical management of knee osteoarthritis. Osteoarthritis Cartilage 2014; 22: 363 – 88.
dc.identifier.citedreferenceBannuru RR, Schmid CH, Kent DM, Vaysbrot EE, Wong JB, McAlindon TE, et al. Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta‐analysis. Ann Intern Med 2015; 162: 46 – 54.
dc.identifier.citedreferenceRoberts E, Nunes VD, Buckner S, Latchem S, Constanti M, Miller P, et al. Paracetamol: not as safe as we thought? A systematic literature review of observational studies. Ann Rheum Dis 2016; 75: 552 – 9.
dc.identifier.citedreferenceDa Costa BR, Reichenbach S, Keller N, Nartey L, Wandel S, Juini P, et al. Effectiveness of nonsteroidal anti‐inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta‐analysis. Lancet 2017; 390: e21 – 33.
dc.identifier.citedreferenceLories RJ, Corr M, Lane NE. To Wnt or not to Wnt: the bone and joint health dilemma [review]. Nat Rev Rheumatol 2013; 9: 328 – 39.
dc.identifier.citedreferenceThysen S, Luyten FP, Lories RJ. Loss of Frzb and Sfrp1 differentially affects joint homeostasis in instability‐induced osteoarthritis. Osteoarthritis Cartilage 2015; 23: 275 – 9.
dc.identifier.citedreferenceDe Boer J, Wang HJ, van Blitterswijk C. Effects of Wnt signaling on proliferation and differentiation of human mesenchymal stem cells. Tissue Eng 2004; 393 – 401.
dc.identifier.citedreferenceYano F, Kugimiya F, Ohba S, Ikeda T, Chikuda H, Ogasawara T, et al. The canonical Wnt signaling pathway promotes chondrocyte differentiation in a Sox9–dependent manner. Biochem Biophys Res Comm 2005; 333: 1300 – 8.
dc.identifier.citedreferenceDay TF, Guo X, Garrett‐Beal L, Yang Y. Wnt/β‐catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev Cell 2005; 8: 739 – 50.
dc.identifier.citedreferenceLories RJ, Peeters J, Bakker A, Tylzanowski P, Derese I, Schrooten J, et al. Articular cartilage and biomechanical properties of the long bones in Frzb‐knockout mice. Arthritis Rheum 2007; 56: 4095 – 103.
dc.identifier.citedreferenceLoughlin J, Dowling B, Chapman K, Marcelline L, Mustafa Z, Southam L, et al. Functional variants within the secreted frizzled‐related protein 3 gene are associated with hip osteoarthritis in females. Proc Natl Acad Sci U S A 2004; 9757 – 62.
dc.identifier.citedreferenceZhu M, Tang D, Wu Q, Hao S, Chen M, Xie C, et al. Activation of β‐catenin signaling in articular chondrocytes leads to osteoarthritis‐like phenotype in adult β‐catenin conditional activation mice. J Bone Miner Res 2009; 24: 12 – 21.
dc.identifier.citedreferenceUsami Y, Gunawardena AT, Iwamoto M, Enomoto‐Iwamoto M. Wnt signaling in cartilage development and diseases: lessons from animal studies. Lab Invest 2016; 96: 186 – 96.
dc.identifier.citedreferenceDiarra D, Stolina M, Polzer K, Zwerina J, Ominsky MS, Dwyer D, et al. Dickkopf‐1 is a master regulator of joint remodeling. Nat Med 2007; 13: 156 – 63.
dc.identifier.citedreferenceKronke G, Uderhardt S, Kim K, Stock M, Scholtysek C, Zaiss MM, et al. R‐spondin 1 protects against inflammatory bone damage during murine arthritis by modulating the Wnt pathway. Arthritis Rheum 2010; 62: 2303 – 12.
dc.identifier.citedreferenceZhu M, Chen M, Zuscik M, Quiquian W, Wang YJ, Rosier RN, et al. Inhibition of β‐catenin signaling in articular chondrocytes results in articular cartilage destruction. Arthritis Rheum 2008; 58: 2053 – 64.
dc.identifier.citedreferenceDeshmukh V, Hu H, Barroga C, Bossard C, Kc S, Dellamary L, et al. A small‐molecule inhibitor of the Wnt pathway (LOR) as a potential disease modifying agent for the treatment of osteoarthritis of the knee. Osteoarthritis Cartilage 2018; 26: 18 – 27.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
art41315.pdf
Size:
923.2KB
Format:
PDF
View/Open
Name:
art41315_am.pdf
Size:
485.0KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.